Maternal and fetal outcomes of pregnant women on antiretroviral (ARV) therapy at Dr George Mukhari hospital :a case-controlled clinical study

dc.contributor.author	Mavukani, M. P.
dc.date.accessioned	2011-01-28T08:18:14Z
dc.date.available	2011-01-28T08:18:14Z
dc.date.issued	2009
dc.date.submitted	2009
dc.identifier.uri	http://hdl.handle.net/10386/274
dc.description	Thesis (M Med.(Obstetrics & Gynecology))--University of Limpopo,2009.	en
dc.description.abstract	OBJECTIVE: The objectives of the study were: 1) To determine the pattern of toxicity/side-effects among women using Highly Active Antiretroviral Therapy (HAART) in the perinatal period in comparison with women who were treated with intra- partum prophylaxis of nevirapine at the time of delivery. 2) To evaluate the effects of either approach of therapy on maternal and fetal outcomes. METHODOLOGY: STUDY DESIGN The department of Obstetrics and Gynaecology has begun to administer HAART to pregnant women identified for ARV programme. These women were counseled and recruited prospectively for the study. The study involved comparison of pregnancy outcomes between women identified for HAART and those who were HIV infected but who only required intra-partum prophylaxis in labour to prevent mother-to-child transmission of HIV with nevirapine.	en
dc.language.iso	en	en
dc.publisher	University of Limpopo (Medunsa Campus)	en
dc.subject	Antiretroviral therapy	en
dc.subject	Pregnant women	en
dc.title	Maternal and fetal outcomes of pregnant women on antiretroviral (ARV) therapy at Dr George Mukhari hospital :a case-controlled clinical study	en
dc.type	Thesis	en